Cover Image
市場調查報告書

生物性骨材的全球市場:2016∼2020年

Global Orthobiologics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 353173
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
生物性骨材的全球市場:2016∼2020年 Global Orthobiologics Market 2016-2020
出版日期: 2016年02月17日 內容資訊: 英文 76 Pages
簡介

生物性骨材是採用以生醫材料與細胞為基礎的治療,修復骨頭和防止骨的退化,求取穩定性的最新醫療領域。透過生物性骨材的技術創新,造成加速骨的治癒流程的骨移植和組織再生產品的開發。全球生物性骨材市場,預計2016∼2020年以年複合成長率7.03%擴大。

本報告提供全球生物性骨材市場現狀與今後的成長預測,各地區趨勢,以及市場趨勢與課題,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 生物性骨材開發資金

  • 臨床實驗中的生物性骨材產品

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

第8章 各治療市場區隔

  • 脊椎融合手術
  • 整形外科外傷及重組手術

第9章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

第11章 促進要素的影響

第12章 市場課題

第13章 促進要素及課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

圖表

目錄
Product Code: IRTNTR8261

About Orthobiologics

Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Orthobiologic products are obtained from naturally occurring materials. These products help treat people with long-term disabling musculoskeletal disorders and injuries. Innovations in orthobiologics led to the development of bone grafts and tissue regeneration products that accelerate the bone healing process, reducing hospital visits, and stays.

Technavio's analysts forecast the global orthobiologics market to grow at a CAGR of 7.03% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global orthobiologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:

  • Stem cells
  • Bone morphogenetic proteins
  • Synthetic bone grafts
  • Viscosupplements
  • Demineralized bone matrix
  • Allografts

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Orthobiologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet

Other Prominent Vendors

  • Alphatec Spine
  • AlloSource
  • AMEDICA
  • Anika Therapeutics
  • Arthrex
  • Baxter
  • BBS-Bioactive Bone Substitutes
  • Berkeley Advanced Biomaterial
  • Biomimetic Therapeutics
  • Bioventus
  • Bone Therapeutics
  • Ceramisys
  • Geistlich Bio-Oss
  • Graftys
  • Integra Life Sciences
  • ISTO Technologies
  • Keramat
  • K2M
  • NovaBone
  • Orthogem
  • Orthofix International
  • OsteoMed
  • RTI Surgical
  • Sigma Graft
  • Smith & Nephew
  • Straumann
  • Wright Medical
  • Xtant Medical

Market driver

  • Rise in strategic partnerships for marketing
  • For a full, detailed list, view our report

Market challenge

  • High cost of spine fusion surgery
  • For a full, detailed list, view our report

Market trend

  • Funds to enhance orthobiologics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Funding for orthobiologics development

  • Orthobiologic products under clinical trial

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product

  • Global orthobiologics market by stem cells
  • Global orthobiologics market by bone morphogenetic proteins
  • Global orthobiologics market by synthetic bone grafts
  • Global orthobiologics market by viscosupplements
  • Global orthobiologics market by demineralized bone matrix
  • Global orthobiologics market by allografts

PART 08: Market segmentation by procedure

  • Spinal fusion surgery
  • Orthopedic trauma and reconstruction surgery

PART 09: Geographical segmentation

  • Orthobiologics market in Americas
  • Orthobiologics market in EMEA
  • Orthobiologics market in APAC

PART 10: Market drivers

  • Popularity of spinal fusion surgeries
  • Rise in strategic partnerships for marketing
  • Prevalence of arthritis

PART 11: Impact of drivers

PART 12: Market challenges

  • High cost of spinal fusion surgery
  • Product side effects and FDA scrutiny
  • Poor performance of bone graft substitute

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Funds to enhance orthobiologics
  • Product development in collaboration with research institutes
  • Increase in M&A

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings 7
  • Exhibit 02: Funding for orthobiologics development
  • Exhibit 03: Global orthobiologics market segmentation by product and procedure
  • Exhibit 04: Global orthobiologics market 2015-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global orthobiologics market by product 2015
  • Exhibit 07: Global orthobiologics market by stem cells 2015-2020 ($ millions)
  • Exhibit 08: Global orthobiologics market by bone morphogenetic proteins 2015-2020 ($ millions)
  • Exhibit 09: Global orthobiologics market by synthetic bone grafts 2015-2020 ($ millions)
  • Exhibit 10: Global orthobiologics market by viscosupplements 2015-2020 ($ billions)
  • Exhibit 11: Global orthobiologics market by demineralized bone matrix 2015-2020 ($ millions)
  • Exhibit 12: Global orthobiologics market by allografts 2015-2020 ($ millions)
  • Exhibit 13: Global orthobiologics market by procedure 2015
  • Exhibit 14: Global orthobiologics market by geography 2015
  • Exhibit 15: Orthobiologics market in Americas 2015-2020 ($ billions)
  • Exhibit 16: Orthobiologics market in EMEA 2015-2020 ($ billions)
  • Exhibit 17: Orthobiologics market in APAC 2015-2020 ($ millions)
  • Exhibit 18: Global orthobiologics market by geography 2015-2020
  • Exhibit 19: Impact of drivers
  • Exhibit 20: Impact of drivers and challenges
  • Exhibit 21: Ranking of vendors 2015
  • Exhibit 22: Competitive scenario of vendors 2015
  • Exhibit 23: Comparative analysis of vendors and their orthobiologic products
  • Exhibit 24: Collaboration between vendors and universities or organizations
  • Exhibit 25: DePuy Synthes: Key takeaways
  • Exhibit 26: DePuy Synthes: Business segmentation
  • Exhibit 27: Medtronic: Key takeaways
  • Exhibit 28: Medtronic: Business segmentation by revenue 2015
  • Exhibit 29: Sanofi: Key takeaways
  • Exhibit 30: Sanofi: Product revenue 2014
  • Exhibit 31: Sanofi: Product revenue comparison 2013 and 2014 ($ millions)
  • Exhibit 32: Stryker: Key takeaways
  • Exhibit 33: Stryker: Business segmentation by revenue 2014
  • Exhibit 34: Stryker: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 35: Stryker: Geographical segmentation by revenue 2014
  • Exhibit 36: Zimmer Biomet: Key takeaways
  • Exhibit 37: Zimmer Biomet: Business segmentation by revenue 2014
  • Exhibit 38: Zimmer Biomet: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 39: Zimmer Biomet: Geographical segmentation by revenue 2014
Back to Top